{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Huntington\u2019s disease", "Parkinson\u2019s disease", "aging", "ampelopsin", "dihydromyricetin", "neurodegenerative diseases"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31780947", "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "11"}], "Language": ["eng"], "ELocationID": ["1334", "10.3389/fphar.2019.01334"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases.", "Pagination": {"StartPage": "1334", "MedlinePgn": "1334"}, "Abstract": {"AbstractText": ["Brain aging and neurodegenerative diseases share the hallmarks of slow and progressive loss of neuronal cells. Flavonoids, a subgroup of polyphenols, are broadly present in food and beverage and numerous studies have suggested that it could be useful for preventing or treating neurodegenerative diseases in humans. Dihydromyricetin (DHM) is one of the main flavonoids of some Asian medicinal plants that are used to treat diverse illness. The effects of DHM have been studied in different <i>in vitro</i> systems of oxidative damage and neuroinflammation, as well as in animal models of several neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Here we analyzed the most important effects of DHM, including its antioxidant, anti-inflammatory, and neuroprotective effects, as well as its ability to restore GABA neurotransmission and improve motor and cognitive behavior. We propose new areas of research that might contribute to a better understanding of the mechanism of action of this flavonoid, which could help develop a new therapy for aging and age-related brain diseases."], "CopyrightInformation": "Copyright \u00a9 2019 Mart\u00ednez-Coria, Mendoza-Rojas, Arrieta-Cruz and L\u00f3pez-Vald\u00e9s."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division de Investigaci\u00f3n, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM), Ciudad de M\u00e9xico, M\u00e9xico."}, {"Identifier": [], "Affiliation": "Laboratorio Experimental de Enfermedades Neurodegenerativas, UNAM-INNyN, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \"Manuel Velasco Su\u00e1rez\",Ciudad de M\u00e9xico, Mexico."}], "LastName": "Mart\u00ednez-Coria", "ForeName": "Hilda", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unidad Perif\u00e9rica de Neurociencias, UNAM-INNyN, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \"Manuel Velasco Su\u00e1rez\",Ciudad de M\u00e9xico, Mexico."}], "LastName": "Mendoza-Rojas", "ForeName": "Martha X", "Initials": "MX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Investigaci\u00f3n B\u00e1sica, Instituto Nacional de Geriatr\u00eda,Ciudad de M\u00e9xico, Mexico."}], "LastName": "Arrieta-Cruz", "ForeName": "Isabel", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division de Investigaci\u00f3n, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM), Ciudad de M\u00e9xico, M\u00e9xico."}, {"Identifier": [], "Affiliation": "Unidad Perif\u00e9rica de Neurociencias, UNAM-INNyN, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \"Manuel Velasco Su\u00e1rez\",Ciudad de M\u00e9xico, Mexico."}], "LastName": "L\u00f3pez-Vald\u00e9s", "ForeName": "H\u00e9ctor E", "Initials": "HE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ameen F., AlYahya S. A., Bakhrebah M. A., Nassar M. S., Aljuraifani A. (2018). Flavonoid dihydromyricetin-mediated silver nanoparticles as potential nanomedicine for biomedical treatment of infections caused by opportunistic fungal pathogens. Res. Chem. Intermed. 44, 5063\u20135073. 10.1007/s11164-018-3409-x", "ArticleIdList": ["10.1007/s11164-018-3409-x"]}, {"Citation": "Blandini F., Armentero M.-T. (2012). Animal models of Parkinson\u2019s disease. FEBS J. 279, 1156\u20131166. 10.1111/j.1742-4658.2012.08491.x", "ArticleIdList": ["10.1111/j.1742-4658.2012.08491.x", "22251459"]}, {"Citation": "Chen S., Zhao X., Wan J., Ran L., Qin Y., Wang X., et al. (2015). Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. Pharmacol. Res. 99, 74\u201381. 10.1016/j.phrs.2015.05.009", "ArticleIdList": ["10.1016/j.phrs.2015.05.009", "26032587"]}, {"Citation": "Choi J. Y., Morris J. C., Hsu C. Y. (1998). Aging and cerebrovascular disease. Neurol. Clin. 16, 687\u2013711. 10.1016/S0733-8619(05)70089-X", "ArticleIdList": ["10.1016/S0733-8619(05)70089-X", "9666045"]}, {"Citation": "Collier T. J., Kanaan N. M., Kordower J. H. (2011). Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat. Rev. Neurosci. 12, 359\u2013366. 10.1038/nrn3039", "ArticleIdList": ["10.1038/nrn3039", "PMC3387674", "21587290"]}, {"Citation": "Dalcin A. J. F., Vizzotto B. S., Bochi G. V., Guarda N. S., Nascimento K., Sagrillo M. R., et al. (2019). Nanoencapsulation of the flavonoid dihydromyricetin protects against the genotoxicity and cytotoxicity induced by cationic nanocapsules. Colloids Surf. B Biointerfaces 173, 798\u2013805. 10.1016/j.colsurfb.2018.10.066", "ArticleIdList": ["10.1016/j.colsurfb.2018.10.066", "30551295"]}, {"Citation": "Davis J., Xu F., Deane R., Romanov G., Previti M. L., Zeigler K., et al. (2004). Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279, 20296\u201320306. 10.1074/jbc.M312946200", "ArticleIdList": ["10.1074/jbc.M312946200", "14985348"]}, {"Citation": "Fan L., Tong Q., Dong W., Yang G., Hou X., Xiong W., et al. (2017). Tissue Distribution, Excretion, and Metabolic Profile of Dihydromyricetin, a Flavonoid from Vine Tea (Ampelopsis grossedentata) after Oral Administration in Rats. J. Agric. Food Chem. 65, 4597\u20134604. 10.1021/acs.jafc.7b01155", "ArticleIdList": ["10.1021/acs.jafc.7b01155", "28534405"]}, {"Citation": "Feng J., Wang J., Du Y., Liu Y., Zhang W., Chen J., et al. (2018). Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice. CNS Neurosci. Ther. 24, 1207\u20131218. 10.1111/cns.12983", "ArticleIdList": ["10.1111/cns.12983", "PMC6282966", "29869390"]}, {"Citation": "Golpich M., Amini E., Hemmati F., Ibrahim N. M., Rahmani B., Mohamed Z., et al. (2015). Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: Implications for Parkinson\u2019s disease. Pharmacol. Res. 97, 16\u201326. 10.1016/j.phrs.2015.03.010", "ArticleIdList": ["10.1016/j.phrs.2015.03.010", "25829335"]}, {"Citation": "He G., Du F., Yang W., Pei G., Zhu Y. (2003. a). Effects of tengcha flavonoids on scavenging oxygen free radicals and inhibiting lipid-peroxidation. Zhong Yao Cai Zhongyaocai J. Chin. Med. Mater. 26, 338\u2013340.", "ArticleIdList": ["14535015"]}, {"Citation": "He G., Yang W., Pei G., Zhu Y., Du F. (2003. b). Studies on the effect of dihydromyricetin on antilipid-peroxidation. Zhongguo Zhong Yao Za Zhi Zhongguo Zhongyao Zazhi China J. Chin. Mater. Med. 28, 1188\u20131190.", "ArticleIdList": ["15617509"]}, {"Citation": "Heneka M. T., McManus R. M., Latz E. (2018). Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 19, 610\u2013621. 10.1038/s41583-018-0055-7", "ArticleIdList": ["10.1038/s41583-018-0055-7", "30206330"]}, {"Citation": "Hou X. L., Tong Q., Wang W. Q., Shi C. Y., Xiong W., Chen J., et al. (2015). Suppression of inflammatory responses by dihydromyricetin, a flavonoid from ampelopsis grossedentata, via inhibiting the activation of NF-\u03baB and MAPK Signaling Pathways. J. Nat. Prod. 78, 1689\u20131696. 10.1021/acs.jnatprod.5b00275", "ArticleIdList": ["10.1021/acs.jnatprod.5b00275", "26171689"]}, {"Citation": "Hu Q., Zhang T., Yi L., Zhou X., Mi M. (2018). Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells. BioFactors Oxf. Engl. 44, 123\u2013136. 10.1002/biof.1395", "ArticleIdList": ["10.1002/biof.1395", "29193391"]}, {"Citation": "Hyun T., Eom S., Yu C., Roitsch T. (2010). Hovenia dulcis \u2013 An Asian Traditional Herb. Planta Med. 76, 943\u2013949. 10.1055/s-0030-1249776", "ArticleIdList": ["10.1055/s-0030-1249776", "20379955"]}, {"Citation": "Jiang B., Le L., Pan H., Hu K., Xu L., Xiao P. (2014). Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells. Brain Res. Bull. 109, 117\u2013126. 10.1016/j.brainresbull.2014.10.010", "ArticleIdList": ["10.1016/j.brainresbull.2014.10.010", "25451453"]}, {"Citation": "Katz M. J., Lipton R. B., Hall C. B., Zimmerman M. E., Sanders A. E., Verghese J., et al. (2012). Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis. Assoc. Disord. 26, 335\u2013343. 10.1097/WAD.0b013e31823dbcfc", "ArticleIdList": ["10.1097/WAD.0b013e31823dbcfc", "PMC3334445", "22156756"]}, {"Citation": "Kou X., Chen N. (2012). Pharmacological potential of ampelopsin in Rattan tea. Food Sci. Hum. Wellness 1, 14\u201318. 10.1016/j.fshw.2012.08.001", "ArticleIdList": ["10.1016/j.fshw.2012.08.001"]}, {"Citation": "Kou X., Liu X., Chen X., Li J., Yang X., Fan J., et al. (2016). Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway. Oncotarget 7, 74484\u201374495. 10.18632/oncotarget.12811", "ArticleIdList": ["10.18632/oncotarget.12811", "PMC5342681", "27780933"]}, {"Citation": "Li X., Liu J., Lin J., Wang T., Huang J., Lin Y., et al. (2016). Protective Effects of Dihydromyricetin against \u2022OH-Induced Mesenchymal Stem Cells Damage and Mechanistic Chemistry. Mol. Basel Switz. 21, 604. 10.3390/molecules21050604", "ArticleIdList": ["10.3390/molecules21050604", "PMC6274564", "27171068"]}, {"Citation": "Liang J., L\u00f3pez-Vald\u00e9s H. E., Mart\u00ednez-Coria H., Lindemeyer A. K., Shen Y., Shao X. M., et al. (2014). Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer\u2019s disease. Neurochem. Res. 39, 1171\u20131181. 10.1007/s11064-014-1304-4", "ArticleIdList": ["10.1007/s11064-014-1304-4", "24728903"]}, {"Citation": "Lindsay J., Laurin D., Verreault R., H\u00e9bert R., Helliwell B., Hill G. B., et al. (2002). Risk factors for Alzheimer\u2019s disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 156, 445\u2013453. 10.1093/aje/kwf074", "ArticleIdList": ["10.1093/aje/kwf074", "12196314"]}, {"Citation": "Liu L., Yin X., Wang X., Li X. (2017). Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Pharm. Biol. 55, 657\u2013662. 10.1080/13880209.2016.1266669", "ArticleIdList": ["10.1080/13880209.2016.1266669", "PMC6130699", "27951743"]}, {"Citation": "L\u00f3pez-Ot\u00edn C., Blasco M. A., Partridge L., Serrano M., Kroemer G. (2013). The hallmarks of aging. Cell 153, 1194\u20131217. 10.1016/j.cell.2013.05.039", "ArticleIdList": ["10.1016/j.cell.2013.05.039", "PMC3836174", "23746838"]}, {"Citation": "L\u00f3pez-Vald\u00e9s H. E., Mart\u00ednez-Coria H. (2016). The Role of Neuroinflammation in Age-Related Dementias. Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr. 68, 40\u201348.", "ArticleIdList": ["27028176"]}, {"Citation": "Luo Y., Lu S., Dong X., Xu L., Sun G., Sun X. (2017). Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway. Apoptosis Int. J. Program. Cell Death 22, 1013\u20131024. 10.1007/s10495-017-1381-3", "ArticleIdList": ["10.1007/s10495-017-1381-3", "28612103"]}, {"Citation": "Mu S., Li Y., Liu B., Wang W., Chen S., Wu J., et al. (2016). Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats. J. Mol. Neurosci. MN 60, 267\u2013275. 10.1007/s12031-016-0801-0", "ArticleIdList": ["10.1007/s12031-016-0801-0", "27501707"]}, {"Citation": "OECD (2001. a). Guidance Document on Acute oral Toxicity Testing: Organisation for Economic Co-operation and Development (OECD) Paris (FR); 2001; Report No.: ENV/JM/MONO(2001)4."}, {"Citation": "OECD (2001. b). Guideline for the Testing of Chemicals: Acute Oral Toxicity\u2014Up-and Down Procedure (TG 425): Organisation for Economic Co-operation and Development (OECD) Paris (FR); 2001; adopted: 21st September 1998; revised method adopted: 17th December 2001."}, {"Citation": "Qi S., Xin Y., Guo Y., Diao Y., Kou X., Luo L., et al. (2012). Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-\u03baB signaling pathways. Int. Immunopharmacol. 12, 278\u2013287. 10.1016/j.intimp.2011.12.001", "ArticleIdList": ["10.1016/j.intimp.2011.12.001", "22193240"]}, {"Citation": "Raitoharju E., Lyytik\u00e4inen L.-P., Levula M., Oksala N., Mennander A., Tarkka M., et al. (2011). miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219, 211\u2013217. 10.1016/j.atherosclerosis.2011.07.020", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.07.020", "21820659"]}, {"Citation": "Ren Z., Zhao Y., Cao T., Zhen X. (2017). Erratum: Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson\u2019s disease by suppressing glycogen synthase kinase-3 beta activity. Acta Pharmacol. Sin. 38, 733. 10.1038/aps.2017.40", "ArticleIdList": ["10.1038/aps.2017.40", "PMC5057232", "27374489"]}, {"Citation": "Ruan L.-P., Yu B.-Y., Fu G.-M., Zhu D. (2005). Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 38, 457\u2013464. 10.1016/j.jpba.2005.01.030", "ArticleIdList": ["10.1016/j.jpba.2005.01.030", "15925247"]}, {"Citation": "Saito S., Yamamoto Y., Maki T., Hattori Y., Ito H., Mizuno K., et al. (2017). Taxifolin inhibits amyloid-\u03b2 oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol. Commun. 5, 26. 10.1186/s40478-017-0429-5", "ArticleIdList": ["10.1186/s40478-017-0429-5", "PMC5379578", "28376923"]}, {"Citation": "Sato M., Murakami K., Uno M., Nakagawa Y., Katayama S., Akagi K., et al. (2013). Site-specific inhibitory mechanism for amyloid \u03b242 aggregation by catechol-type flavonoids targeting the Lys residues. J. Biol. Chem. 288, 23212\u201323224. 10.1074/jbc.M113.464222", "ArticleIdList": ["10.1074/jbc.M113.464222", "PMC3743493", "23792961"]}, {"Citation": "Shwe T., Pratchayasakul W., Chattipakorn N., Chattipakorn S. C. (2018). Role of D-galactose-induced brain aging and its potential used for therapeutic interventions. Exp. Gerontol. 101, 13\u201336. 10.1016/j.exger.2017.10.029", "ArticleIdList": ["10.1016/j.exger.2017.10.029", "29129736"]}, {"Citation": "Singh A., Kukreti R., Saso L., Kukreti S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Mol. Basel Switz. 24, 1583. 10.3390/molecules24081583", "ArticleIdList": ["10.3390/molecules24081583", "PMC6514564", "31013638"]}, {"Citation": "Solanki S. S., Sarkar B., Dhanwani R. K. (2012). Microemulsion drug delivery system: for bioavailability enhancement of ampelopsin. ISRN Pharm. 2012, 108164. 10.5402/2012/108164", "ArticleIdList": ["10.5402/2012/108164", "PMC3399350", "22830055"]}, {"Citation": "Song Q., Liu L., Yu J., Zhang J., Xu M., Sun L., et al. (2017). Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress. Eur. J. Pharmacol. 807, 159\u2013167. 10.1016/j.ejphar.2017.04.014", "ArticleIdList": ["10.1016/j.ejphar.2017.04.014", "28414055"]}, {"Citation": "Sun P., Yin J.-B., Liu L.-H., Guo J., Wang S.-H., Qu C.-H., et al. (2019). Protective role of Dihydromyricetin in Alzheimer\u2019s disease rat model associated with activating AMPK/SIRT1 signaling pathway. Biosci. Rep. 39. 10.1042/BSR20180902", "ArticleIdList": ["10.1042/BSR20180902", "PMC6328867", "30498091"]}, {"Citation": "Tang N., Ma J., Wang K. S., Mi C., Lv Y., Piao L. X., et al. (2016). Dihydromyricetin suppresses TNF-\u03b1-induced NF-\u03baB activation and target gene expression. Mol. Cell. Biochem. 422, 11\u201320. 10.1007/s11010-016-2799-6", "ArticleIdList": ["10.1007/s11010-016-2799-6", "27686451"]}, {"Citation": "Tsao R. (2010). Chemistry and Biochemistry of Dietary Polyphenols. Nutrients 2, 1231\u20131246. 10.3390/nu2121231", "ArticleIdList": ["10.3390/nu2121231", "PMC3257627", "22254006"]}, {"Citation": "Wang C., Tong Q., Hou X., Hu S., Fang J., Sun C. C. (2016). Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor. Cryst. Growth Des. 16, 5030\u20135039. 10.1021/acs.cgd.6b00591", "ArticleIdList": ["10.1021/acs.cgd.6b00591"]}, {"Citation": "Wang Y., Wang Q., Bao X., Ding Y., Shentu J., Cui W., et al. (2018). Taxifolin prevents \u03b2-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2/prostaglandin E2 content. Metab. Brain Dis. 33, 1069\u20131079. 10.1007/s11011-018-0207-5", "ArticleIdList": ["10.1007/s11011-018-0207-5", "29542038"]}, {"Citation": "Xiang D., Fan L., Hou X.-L., Xiong W., Shi C.-Y., Wang W.-Q., et al. (2018). Uptake and Transport Mechanism of Dihydromyricetin Across Human Intestinal Caco-2 Cells. J. Food Sci. 83, 1941\u20131947. 10.1111/1750-3841.14112", "ArticleIdList": ["10.1111/1750-3841.14112", "29969512"]}, {"Citation": "Yang D., Tan S., Yang Z., Jiang P., Qin C., Yuan Q., et al. (2018). Dihydromyricetin attenuates TNF-\u03b1-induced endothelial dysfunction through miR-21-mediated DDAH1/ADMA/NO signal pathway. BioMed. Res. Int. 2018. 10.1155/2018/1047810", "ArticleIdList": ["10.1155/2018/1047810", "PMC5850903", "29682517"]}, {"Citation": "Yang J.-G., Liu B.-G., Liang G.-Z., Ning Z.-X. (2009). Structure-activity relationship of flavonoids active against lard oil oxidation based on quantum chemical analysis. Mol. Basel Switz. 14, 46\u201352. 10.3390/molecules14010046", "ArticleIdList": ["10.3390/molecules14010046", "PMC6253939", "19104485"]}, {"Citation": "Zhang Q., Liu J., Liu B., Xia J., Chen N., Chen X., et al. (2014). Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Sci. Rep. 4, 4628. 10.1038/srep04628", "ArticleIdList": ["10.1038/srep04628", "PMC3982169", "24717393"]}, {"Citation": "Zhang Y., Ning Z., Yang S., Wu H. (2003). Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata. Yao Xue Xue Bao 38, 241\u2013244.", "ArticleIdList": ["12889119"]}, {"Citation": "Zhang Y., Que S., Yang X., Wang B., Qiao L., Zhao Y. (2007). Isolation and identification of metabolites from dihydromyricetin. Magn. Reson. Chem. MRC 45, 909\u2013916. 10.1002/mrc.2051", "ArticleIdList": ["10.1002/mrc.2051", "17924358"]}, {"Citation": "Zhao X., Shi C., Zhou X., Lin T., Gong Y., Yin M., et al. (2019). Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 138, 104994. 10.1016/j.ejps.2019.104994", "ArticleIdList": ["10.1016/j.ejps.2019.104994", "31302210"]}, {"Citation": "Zhou T., Zhou X. (1996). Isolation, structure determination and pharmacological activity of flavanonol from ampelopsis grossedentata. Chin. Pharm. J. 458\u2013461."}]}], "History": [{"Year": "2019", "Month": "7", "Day": "22"}, {"Year": "2019", "Month": "10", "Day": "18"}, {"Year": "2019", "Month": "11", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "11", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["31780947", "PMC6859532", "10.3389/fphar.2019.01334"]}}]}